[{"address1": "18000 Studebaker Road", "address2": "Suite 800", "city": "Cerritos", "state": "CA", "zip": "90703", "country": "United States", "phone": "562 735 3226", "website": "https://theoncologyinstitute.com", "industry": "Medical Care Facilities", "industryKey": "medical-care-facilities", "industryDisp": "Medical Care Facilities", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.", "fullTimeEmployees": 800, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard Alan Barasch", "age": 69, "title": "Chairman of the Board", "yearBorn": 1954, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel  Virnich FACHE, M.B.A., M.D.", "age": 44, "title": "CEO & Executive Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 614620, "exercisedValue": 0, "unexercisedValue": 541180}, {"maxAge": 1, "name": "Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 535360, "exercisedValue": 0, "unexercisedValue": 140679}, {"maxAge": 1, "name": "Mr. Rob  Carter", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeremy N. Castle M.B.A.", "age": 40, "title": "Chief Operations Officer", "yearBorn": 1983, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hueppelsheuser Esq.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laura  Szitar", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jordan  McInerney", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 9, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.23, "open": 0.2314, "dayLow": 0.207, "dayHigh": 0.2388, "regularMarketPreviousClose": 0.23, "regularMarketOpen": 0.2314, "regularMarketDayLow": 0.207, "regularMarketDayHigh": 0.2388, "beta": 0.616, "forwardPE": -1.393125, "volume": 236440, "regularMarketVolume": 236440, "averageVolume": 1589195, "averageVolume10days": 3245120, "averageDailyVolume10Day": 3245120, "bid": 0.222, "ask": 0.2292, "bidSize": 100, "askSize": 100, "marketCap": 16842124, "fiftyTwoWeekLow": 0.125, "fiftyTwoWeekHigh": 2.5, "priceToSalesTrailing12Months": 0.046645425, "fiftyDayAverage": 0.26024, "twoHundredDayAverage": 0.63485, "currency": "USD", "enterpriseValue": 92398360, "profitMargins": -0.19814, "floatShares": 45910296, "sharesOutstanding": 75559104, "sharesShort": 247975, "sharesShortPriorMonth": 252527, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0033000002, "heldPercentInsiders": 0.19555001, "heldPercentInstitutions": 0.47594002, "shortRatio": 3.38, "shortPercentOfFloat": 0.005, "impliedSharesOutstanding": 75559104, "bookValue": 0.769, "priceToBook": 0.28985697, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -58507000, "trailingEps": -0.77, "forwardEps": -0.16, "enterpriseToRevenue": 0.256, "enterpriseToEbitda": -1.611, "52WeekChange": -0.8395684, "SandP52WeekChange": 0.2764505, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TOI", "underlyingSymbol": "TOI", "shortName": "The Oncology Institute, Inc.", "longName": "The Oncology Institute, Inc.", "firstTradeDateEpochUtc": 1591277400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "50f4e41b-d240-3030-8d48-ed0199bdd0cc", "messageBoardId": "finmb_661363343", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.2229, "recommendationKey": "none", "totalCash": 46363000, "totalCashPerShare": 0.614, "ebitda": -57338000, "totalDebt": 121006000, "quickRatio": 2.87, "currentRatio": 3.311, "totalRevenue": 361067008, "debtToEquity": 414.319, "revenuePerShare": 4.873, "returnOnAssets": -0.19417, "returnOnEquity": -1.2558999, "freeCashflow": -23950876, "operatingCashflow": -43746000, "revenueGrowth": 0.229, "grossMargins": 0.1533, "ebitdaMargins": -0.1588, "operatingMargins": -0.16600001, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-15"}]